Sidra Medicine concludes MENA Microbiome 2026
<p>Doha, Qatar: Sidra Medicine concluded the last day of MENA Microbiome 2026 with a call to action for stronger collaborative efforts to translate microbiome discoveries into clinical applications to improve disease diagnosis, treatment, and patient outcomes.</p> <p>The day’s official opening featured addresses by Acting Chief Executive Officer and Member of the Board of Governors at Sidra…
Doha, Qatar witnessed the conclusion of the MENA Microbiome 2026 conference at Sidra Medicine, with a call for intensified collaboration to transform microbiome research into clinical applications for enhanced disease diagnosis, treatment, and patient outcomes. The event commenced with opening remarks from Mohammed Khalid Al Mana, Acting Chief Executive Officer and Member of the Board of Governors at Sidra Medicine, along with Professor Ibrahim Janahi, Chief Medical Officer, and Professor Khalid Fakhro, Chief Research Officer.
They underscored the significance of bolstering scientific collaboration, fostering research innovation, and expediting the conversion of scientific breakthroughs into enhanced patient care. Notable attendees included the Minister of Social Development and Family, H.E. Buthaina bint Ali Al Jabr Al-Nuaimi, and esteemed representatives from healthcare and research institutions, alongside global scientific experts.
Al Mana articulated Sidra Medicine's conviction that the future of medicine hinges on not just generating new knowledge but also effectively translating it into tangible benefits for patients and communities. Through this conference, Sidra Medicine sought to fortify regional scientific collaboration, inspire young researchers, and forge partnerships to advance innovative healthcare solutions.
Strategic Sponsor, the Ministry of Public Health of the State of Qatar, was commended for its support and patronage of MENA Microbiome, reflecting a joint dedication to research, innovation, and collaboration for a healthier and more sustainable future for Qatar and the region.
Professor Khalid Fakhro, Chief Research Officer at Sidra Medicine, emphasized the pivotal role of conferences like MENA Microbiome 2026 in establishing a robust dialogue on the multifaceted aspect of research translating into clinical care, extending from the laboratory to bedside and vice versa. He expressed confidence that through multidisciplinary collaboration, significant contributions could be made towards a healthier future for generations to come.
Dr. Jacques Ravel's keynote presentation explored recent advancements in the field of microbiome research, specifically focusing on its implications for women's reproductive health. The presentation also shed light on emerging opportunities for developing targeted interventions to improve reproductive and gynecological health. A highlight of the conference was the panel discussion titled 'Microbiome and Metagenomics: How to Move from Research to Clinical Implementation', featuring Dr. Majdi Osman, Dr. Nikhil Pai, Dr. Mamoun Elawad, and Dr. Sara Abdullah, moderated by Professor Hilal Lashuel.
Written by urgent.news from The Peninsula Qatar's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
